Evaluating the Safety of the SPECTRALIS CENTAURUS Device

Inclusion Criteria: * Written Informed Consent * For Stage 1, any patient aged \>18 years with the need for conventional laser retina ablation * For Stage 2, will be restricted to people aged 50 to \<95 years with lesion characteristics that meet the criteria for intermediate AMD Exclusion Criteria: * Presence of reticular pseudodrusen * Any manifestation of late-stage AMD * Known hypersensitivity or allergy to fluorescein or uncontrolled hypertension * Concomitant systemic corticosteroid treatment for continuous period longer than 2 weeks * History of any vitreous haemorrhage within 4 weeks prior to screening or current haemorrhage in the study eye * Inability to obtain fundus photographs or fluorescein angiogram of sufficient quality * Photosensitive epilepsy * Insufficient retinal pigmentation (albinism) * Corneal opacity / lens opacity * Women of child-bearing potential * Contralateral eye is at an advanced stage of disease and has poor visual acuity * Inability to follow the procedures of the study * Participation in another study with investigational drug within the 30 days preceding and during the present study - Inability or lack of willingness to commit to return for all clinical visits and complete all study-related procedures